Assignee
CELCUITY INC
US·7 granted patents·4 pending applications·12 citations·filing 2016–2025
Top patents by PatentIndex Score
11 records- 0188US11333659B2Methods of measuring signaling pathway activity for selection of therapeutic agentsCELCUITY INC·Filed 2018·Granted May 17, 2022·3 cites·16 claims
- 0288US11073509B2Assays and methods for determining the responsiveness of an individual subject to a therapeutic agentCELCUITY INC·Filed 2016·Granted Jul 27, 2021·5 cites·7 claims
- 0387US10976307B2Whole cell assays and methodsCELCUITY INC·Filed 2018·Granted Apr 13, 2021·2 cites·20 claims
- 0481US11591573B2Methods of preparing a primary cell sampleCELCUITY INC·Filed 2018·Granted Feb 28, 2023·2 cites·10 claims
- 0574US12215356B2Methods of preparing a primary cell sampleCELCUITY INC·Filed 2023·Granted Feb 4, 2025·0 cites·10 claims
- 0674US2021215673A1Whole cell assays and methodsCELCUITY INC·Filed 2021·Application pending·0 cites
- 0772US12320799B2Methods of measuring signaling pathway activity for selection of therapeutic agentsCELCUITY INC·Filed 2022·Granted Jun 3, 2025·0 cites·11 claims
- 0870US12350276B2Methods for the treatment of cancer using 1-(4-{[4-(dimethylamino)piperidin-1-yl]carbonyl}phenyl)-3-[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]ureaCELCUITY INC·Filed 2022·Granted Jul 8, 2025·0 cites·29 claims
- 0968US2025345342A1Methods for the treatment of cancer using 1-(4-{[4-(dimethylamino)piperidin-1-yl]carbonyl}phenyl)-3-[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]ureaCELCUITY INC·Filed 2025·Application pending·0 cites
- 1059US2026053814A1Treatment regimens for gedatolisib in hormonally-driven disordersCELCUITY INC·Filed 2025·Application pending·0 cites
- 1158US2022412957A1Methods of treating cancer patients with ras node or rtk targeted therapeutic agentsCELCUITY INC·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when CELCUITY INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →